Methanobrevibacter smithii
DSM 2374
ARCHAEA
How to read the following data (Example)
Name:
Methanobrevibacter smithii Balch and Wolfe 1981
DSM No.:
2374
Strain designation:
F1
Isolated from:
human faeces
Country:
United States of America
Albany NY
Date of sampling:
before 1981
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- T. L. Miller, New York State Department of Health, Albany, New York, USA; F1 <- T. L. Miller {1980}
Genbank accession numbers:
draft genome: ABYV00000000
Cultivation conditions:
Medium 119 , anaerobic, 37°C
Medium/media recipe(s) required for preparing 119:
- Medium 141
- Medium 320
- Medium 1310
or
Medium 1523 , anaerobic, 37°C
Medium/media recipe(s) required for preparing 1523:
- Medium 320
- Medium 503
Please follow special instructions: 'Cultivation of Anaerobes', 'Cultivation of Methanogens'
Complete DSMZ Media List
Summary and
additional information:
<- T. L. Miller, New York State Department of Health, Albany, New York, USA; F1 <- T. L. Miller {1980}. Human faeces; USA, Albany NY (2410). Sequence accession no. draft genome: ABYV00000000. (Medium 119 or Medium 1523, 37°C, anaerobic).
Literature:
2410
Risk group:
1 (classification according to German TRBA)
Methanobrevibacter smithii 信息由北京百欧博伟生物技术有限公司为您提供,如您想了解更多关于 Methanobrevibacter smithii 报价、型号、参数等信息,欢迎来电或留言咨询。除供应 Methanobrevibacter smithii 外,北京百欧博伟生物技术有限公司还可为您提供 Thermococcus siculi 、Rhodococcus jostii、Rhodococcus maanshanensis 等产品,公司有专业的客户服务团队,是您值得信赖的合作伙伴。